(Source: Global Market Insights)
Experience the Difference
Great Potential
The continuous ageing population, together with growing population of the middle class creates a surge of concern on well-beings of citizens. Healthcare industry has become the top priority in China where the value of such industry is forecast to be RMB 8 trillion by 2020, as proposed in China’s 13th Five-Year Plan (FYP). (Source: KPMG Global China Practice)
Learn moreStrong State Support
Biotechnology industry has been the main target since Chinese government’s previous plan, 12th FYP, where 1.7 trillion was injected into this industry. With the goal of doubling the industry’s scale through scaling up of a new generation of biotechnology products and services in its recent 13th FYP, China’s pharma innovation continues to spur through strong state support
Learn moreBiggest Consumer Market
The current population in China is approximately 1.42 billion which holds around one third of world population. This opens up great opportunities for the development of biotech and healthcare sector.
Learn moreSustainability
Being the present second largest economy in the world, China has been growing at a sustainable GDP growth rate and is forecast to be the largest economy by 2030s.
Learn more